Innovana Thinklabs Ltd

Use of funds and deviation status

• Fundraising mode: preferential issue of convertible warrants.
• Proceeds disclosed; exact amount and subsequent payments details summarized in filing.
• Audit Committee: no deviations observed in utilisation of proceeds.
• Monitoring agency: not applicable.
• Original allocation to general corporate purposes; no modification or deviation.
• Utilisation status: no deviation; proceeds utilised as per stated objects.

Financial results and publication

• Approved the unaudited standalone and consolidated results for quarter ended 30 June 2026.
• Limited Review Reports on both results were taken on record.
• Results to be published in newspapers; available on the company website.
• Trading Window open 48 hours after results declaration.

Auditors and governance disclosures

• Independent auditor’s review reports issued; no material misstatement observed.
• Audit Committee reviewed and recommended the consolidated and standalone results.
• Statutory auditors issued unmodified Limited Review Report.

Fundraising and use of funds

• Annexure reports no deviation in utilization of funds raised via convertible warrants.
• Minimum funds raised: Rs 9.265 crore; balance due on exercise.
• Rs 5.172 crore received through warrant conversion.
• Original object: General Corporate Purposes; remaining proceeds expected within 18 months.
• No investor complaints pending as of 30 June 2026.

Regulatory and disclosures

• Results available on NSE/BSE portals and company website.
• Note: 30 June 2026 filing prepared under SEBI Regulations; details enclosed.

Dematerialisation status

• Regulation 74(5) certificate enclosed; excerpt contains no processing, listing, or mutilation details.

🗓️ Meeting Details

• Board meeting scheduled for 13th February 2026.

📊 Financial Results

• Approval of unaudited standalone and consolidated financial results for quarter and nine months ended 31st December 2025.